Retatrutide is currently in Phase 3 clinical trials, and while it is not FDA approved yet, the results have been very encouraging so far
All GLP-1 medications from licensed 503A compounding pharmacies Browse Products Compare BPC-157 and GHK-Cu peptides: healing mechanisms, clinical efficacy, side effects, and costs
Never stop or adjust your dose without speaking to your PlexusDx provider first, even if you're uncomfortable
Benign human enterovirus becomes virulent in selenium-deficient mice
This randomized phase 2a #ClinicalTrial demonstrates that TPN171H, a potent and selective PDE5 inhibitor, significantly reduces pulmonary vascular resistance and improves acute hemodynamics in patients with #PulmonaryArterialHypertension (PAH), establishing it as a promising and well-tolerated oral therapeutic candidate for managing PAH
The clinical data in this regard is still very limited and needs expanding through randomized, placebo-controlled studies to draw final conclusions on whether polyphenols may be a class of clinically effective nutraceuticals in patients with CFS